My HPRA: Register

ILARIS

150 Milligram Pdr+Solv for Soln for Inj

Novartis Europharm LimitedEU/1/09/564/003

Main Information

Trade NameILARIS
Active SubstancesCANAKINUMAB
Strength150 Milligram
Dosage FormPdr+Solv for Soln for Inj
Licence HolderNovartis Europharm Limited
Licence NumberEU/1/09/564/003

Group Information

ATC CodeL04AC08 Interleukin inhibitors

Status

Authorised/WithdrawnAuthorised
Licence Issued16/09/2011
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing Status--Unknown--
Promotion StatusPromotion to Healthcare Professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription. (See Annex I: Summary of Product Characteristics, section 4.2).

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back
Follow medicine

Print